About UsProductsNewsClinical TrialCorporate RelationsResources

Recent News:

Aug 27, 2010
Ash Access Granted US Patent for Novel Antimicrobial & Antithrombotic Catheter Lock/Flush

Jun 24, 2009
Ash Access Technology's PMA for ZuragenŽ Solution Accepted for Filing by FDA

Aug 22, 2008
Ash Access Technology Completes AZEPTIC Trial for ZuragenŽ Injection

Read a brand new Journal article
from Critical Care Medicine
about our AZEPTIC Trial for Zuragen.
Click here to Read Now: Journal Article, April 2011

Ash Access Technology, Inc. is an integrated specialty pharmaceutical / medical device company engaged in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company has an advanced portfolio of innovative products targeting catheter-related bloodstream infections (CRBSI) and poor patency (blood flow) – the significant challenges associated with the use of both acute and chronic catheters for vascular access. more...